TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
MRVI

Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

8.50$ +7.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow MRVI
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-0.2% 16.8% 53.6% 46.1% 60.7% 43.7% 2.9% -31.0%
18.0% 16.8% 9.1% 3.1% 4.3% 16.9% 21.9% 32.6%
1.7% 1.2% 8.7% 1.3% 2.1% 12.0% 19.1% 16.2%
-3.0% 0.3% -0.1% 5.7% 36.2% – – –
-12.8% 1.6% 12.6% -22.1% -5.1% 33.9% -4.9% -4.3%
2.9% 12.0% 8.9% 1.9% 1.9% 22.7% 11.4% 7.1%
-2.8% -12.0% 2.1% 13.2% -30.3% -42.3% -9.4% -16.9%
42.0% 67.8% 214.5% 19.2% – – – –
0.0% -0.2% -513.2% 0.2% 0.0% 0.0% -0.8% –
44.8% -1.8% 69.3% -0.8% -0.6% -2.0% -90.3% -2.9%
-7.4% -2.9% 18.7% -19.9% -21.2% -21.1% -90.9% -8.9%
-10.4% 2.0% 74.4% 39.4% 9.2% -19.8% -97.4% -56.8%
-3.1% 4.9% 44.6% 44.3% 58.8% 21.0% -8.6% -38.1%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?